US Stock MarketDetailed Quotes

Adaptive Biotechnologies (ADPT)

Watchlist
  • 14.140
  • +0.320+2.32%
Close Apr 24 16:00 ET
  • 14.140
  • 0.0000.00%
Post 17:41 ET
2.18BMarket Cap-36.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptive Biotechnologies (ADPT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.70%-45.99M
116.45%2.06M
73.67%-7.13M
28.16%-12.43M
25.73%-28.48M
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
Net income from continuing operations
62.75%-59.46M
59.73%-13.58M
129.74%9.55M
44.66%-25.59M
37.24%-29.83M
29.16%-159.6M
51.46%-33.72M
36.22%-32.1M
3.27%-46.25M
17.62%-47.53M
Depreciation and amortization
-7.39%17.83M
-5.69%4.2M
-4.05%4.41M
-10.01%4.5M
-9.26%4.73M
-13.38%19.26M
-17.51%4.45M
-20.34%4.59M
-11.50%5M
-3.85%5.21M
Other non cash items
-51.83%3.87M
-54.65%843K
-97.02%56K
-32.50%1.3M
-29.48%1.67M
-35.15%8.04M
-14.45%1.86M
-49.35%1.88M
-36.73%1.93M
-31.52%2.37M
Change In working capital
-230.97%-57.77M
-180.28%-2.45M
-159.98%-33.87M
-287.72%-5.31M
-56.64%-16.14M
62.21%-17.45M
186.93%3.05M
30.13%-13.03M
529.40%2.83M
57.89%-10.31M
-Change in receivables
-130.93%-8.65M
-516.69%-5.54M
89.70%-536K
-110.95%-702K
54.00%-1.86M
-284.25%-3.74M
86.71%-899K
-1,658.08%-5.2M
1,132.37%6.41M
-144.60%-4.05M
-Change in inventory
-118.58%-998K
-100.30%-10K
-179.38%-1.35M
111.61%95K
-76.24%264K
289.29%5.37M
-14.96%3.38M
721.61%1.7M
-1,358.46%-818K
116.82%1.11M
-Change in prepaid assets
-2,187.95%-1.73M
-16.77%799K
-80.41%-2.52M
50.20%-497K
-67.83%489K
104.30%83K
-52.80%960K
67.69%-1.4M
-239.00%-998K
531.82%1.52M
-Change in payables and accrued expense
-0.89%665K
-72.68%1.17M
10,093.22%5.9M
703.19%3.27M
-145.24%-9.67M
112.41%671K
-20.13%4.26M
97.90%-59K
-94.87%407K
75.18%-3.94M
-Change in other working capital
-137.22%-47.06M
124.47%1.14M
-338.56%-35.36M
-243.29%-7.47M
-8.56%-5.37M
47.85%-19.84M
42.51%-4.65M
30.31%-8.06M
71.57%-2.18M
53.89%-4.94M
Cash from discontinued investing activities
Operating cash flow
51.70%-45.99M
116.45%2.06M
73.67%-7.13M
28.16%-12.43M
25.73%-28.48M
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
Investing cash flow
Cash flow from continuing investing activities
-51.22%37.95M
-137.31%-8.25M
226.90%17.28M
-43.07%3.35M
-42.54%25.57M
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
Net PPE purchase and sale
19.24%-2.96M
-695.00%-636K
-18.90%-409K
62.12%-655K
16.68%-1.26M
65.75%-3.66M
93.84%-80K
87.62%-344K
53.23%-1.73M
48.32%-1.51M
Net investment purchase and sale
-49.78%40.91M
-134.31%-7.62M
214.19%17.69M
-47.40%4M
-41.69%26.83M
-41.96%81.46M
392.76%22.2M
-80.53%5.63M
-81.46%7.61M
-30.17%46.02M
Cash from discontinued investing activities
Investing cash flow
-51.22%37.95M
-137.31%-8.25M
226.90%17.28M
-43.07%3.35M
-42.54%25.57M
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
Financing cash flow
Cash flow from continuing financing activities
12,515.35%30.4M
16,953.54%21.66M
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
Proceeds from stock option exercised by employees
7,318.67%17.88M
7,092.13%9.13M
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
Net other financing activities
--12.52M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
12,515.35%30.4M
16,953.54%21.66M
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
Net cash flow
Beginning cash position
-25.26%50.82M
40.58%57.72M
-26.94%45.88M
-28.09%53.36M
-25.26%50.82M
-26.43%68M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
-26.43%68M
Current changes in cash
230.20%22.37M
58.49%15.46M
154.47%11.84M
34.42%-7.47M
-59.03%2.54M
29.69%-17.18M
141.27%9.76M
-5.89%-21.74M
-174.80%-11.4M
37.81%6.2M
End cash Position
44.01%73.18M
44.01%73.18M
40.58%57.72M
-26.94%45.88M
-28.09%53.36M
-25.26%50.82M
-25.26%50.82M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
Free cash flow
50.50%-48.95M
111.29%1.42M
72.51%-7.54M
31.25%-13.09M
25.39%-29.74M
40.80%-98.88M
55.47%-12.57M
44.59%-27.41M
30.17%-19.03M
35.78%-39.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.70%-45.99M116.45%2.06M73.67%-7.13M28.16%-12.43M25.73%-28.48M39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M
Net income from continuing operations 62.75%-59.46M59.73%-13.58M129.74%9.55M44.66%-25.59M37.24%-29.83M29.16%-159.6M51.46%-33.72M36.22%-32.1M3.27%-46.25M17.62%-47.53M
Depreciation and amortization -7.39%17.83M-5.69%4.2M-4.05%4.41M-10.01%4.5M-9.26%4.73M-13.38%19.26M-17.51%4.45M-20.34%4.59M-11.50%5M-3.85%5.21M
Other non cash items -51.83%3.87M-54.65%843K-97.02%56K-32.50%1.3M-29.48%1.67M-35.15%8.04M-14.45%1.86M-49.35%1.88M-36.73%1.93M-31.52%2.37M
Change In working capital -230.97%-57.77M-180.28%-2.45M-159.98%-33.87M-287.72%-5.31M-56.64%-16.14M62.21%-17.45M186.93%3.05M30.13%-13.03M529.40%2.83M57.89%-10.31M
-Change in receivables -130.93%-8.65M-516.69%-5.54M89.70%-536K-110.95%-702K54.00%-1.86M-284.25%-3.74M86.71%-899K-1,658.08%-5.2M1,132.37%6.41M-144.60%-4.05M
-Change in inventory -118.58%-998K-100.30%-10K-179.38%-1.35M111.61%95K-76.24%264K289.29%5.37M-14.96%3.38M721.61%1.7M-1,358.46%-818K116.82%1.11M
-Change in prepaid assets -2,187.95%-1.73M-16.77%799K-80.41%-2.52M50.20%-497K-67.83%489K104.30%83K-52.80%960K67.69%-1.4M-239.00%-998K531.82%1.52M
-Change in payables and accrued expense -0.89%665K-72.68%1.17M10,093.22%5.9M703.19%3.27M-145.24%-9.67M112.41%671K-20.13%4.26M97.90%-59K-94.87%407K75.18%-3.94M
-Change in other working capital -137.22%-47.06M124.47%1.14M-338.56%-35.36M-243.29%-7.47M-8.56%-5.37M47.85%-19.84M42.51%-4.65M30.31%-8.06M71.57%-2.18M53.89%-4.94M
Cash from discontinued investing activities
Operating cash flow 51.70%-45.99M116.45%2.06M73.67%-7.13M28.16%-12.43M25.73%-28.48M39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M
Investing cash flow
Cash flow from continuing investing activities -51.22%37.95M-137.31%-8.25M226.90%17.28M-43.07%3.35M-42.54%25.57M-40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M
Net PPE purchase and sale 19.24%-2.96M-695.00%-636K-18.90%-409K62.12%-655K16.68%-1.26M65.75%-3.66M93.84%-80K87.62%-344K53.23%-1.73M48.32%-1.51M
Net investment purchase and sale -49.78%40.91M-134.31%-7.62M214.19%17.69M-47.40%4M-41.69%26.83M-41.96%81.46M392.76%22.2M-80.53%5.63M-81.46%7.61M-30.17%46.02M
Cash from discontinued investing activities
Investing cash flow -51.22%37.95M-137.31%-8.25M226.90%17.28M-43.07%3.35M-42.54%25.57M-40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M
Financing cash flow
Cash flow from continuing financing activities 12,515.35%30.4M16,953.54%21.66M4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K
Proceeds from stock option exercised by employees 7,318.67%17.88M7,092.13%9.13M4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K
Net other financing activities --12.52M------------------------------------
Cash from discontinued financing activities
Financing cash flow 12,515.35%30.4M16,953.54%21.66M4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K
Net cash flow
Beginning cash position -25.26%50.82M40.58%57.72M-26.94%45.88M-28.09%53.36M-25.26%50.82M-26.43%68M-55.19%41.06M-44.01%62.8M-23.45%74.2M-26.43%68M
Current changes in cash 230.20%22.37M58.49%15.46M154.47%11.84M34.42%-7.47M-59.03%2.54M29.69%-17.18M141.27%9.76M-5.89%-21.74M-174.80%-11.4M37.81%6.2M
End cash Position 44.01%73.18M44.01%73.18M40.58%57.72M-26.94%45.88M-28.09%53.36M-25.26%50.82M-25.26%50.82M-55.19%41.06M-44.01%62.8M-23.45%74.2M
Free cash flow 50.50%-48.95M111.29%1.42M72.51%-7.54M31.25%-13.09M25.39%-29.74M40.80%-98.88M55.47%-12.57M44.59%-27.41M30.17%-19.03M35.78%-39.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -